Stevenson v. La. Patient's Comp. Fund
This text of 710 So. 2d 1178 (Stevenson v. La. Patient's Comp. Fund) is published on Counsel Stack Legal Research, covering Louisiana Court of Appeal primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Opinion
Jean STEVENSON
v.
LOUISIANA PATIENT'S COMPENSATION FUND.
Court of Appeal of Louisiana, Fifth Circuit.
*1180 Bruce A. Cranner, Blue Williams, L.L.P., Metairie, for defendant-appellant.
Darryl J. Tschirn, La Jolla, for plaintiffappellee.
Before GRISBAUM, GAUDIN and CANNELLA, JJ.
GRISBAUM, Judge.
The defendant, Louisiana Patient's Compensation Fund, appeals a jury verdict awarding damages in favor of the plaintiff, Ms. Jean Stevenson, who was misadministered a radioactive isotope (I-131) at Diagnostic Imaging Services, Inc. We affirm.
ISSUE
Our review is focused on the amount of damages awarded.
FACTS AND PROCEDURAL HISTORY
On April 23, 1990, the plaintiff was sent to Diagnostic Imaging Services, Inc. (DIS) for a diagnostic study. Due to a miscommunication between the physician, who scheduled the test, and DIS, a technician at DIS misadministered a radioactive isotope (I-131) to plaintiff, which was ten times the amount of radioactive isotopes normally given to patients for diagnostic purposes. The misadministration was immediately discovered, and plaintiff was informed of the mistake the very next day. The plaintiff was told by Dr. Edward Soll, a diagnostic radiologist and also a co-owner of DIS, that nothing could be done at that point to reverse the effects of the isotope but that plaintiff should submit to further tests to discover the amount of the isotope actually absorbed to determine the long-term consequences. Plaintiff and her husband testified at trial that they were informed by Dr. Soll that the dosage of isotope plaintiff had received put her at a higher risk of developing thyroid cancer, in addition to increased risks of osteoporosis, goiter, and hypothyroidism. Plaintiff declined to submit to further tests and, instead, went to see Dr. Mark Lueg, an endocrinologist, the next day. She was told by Dr. Lueg that the only apparent damage from the isotope was a long-range risk of thyroid failure; however, since the damaging effects of the isotope are not immediate and damage occurs slowly over a period of months, and sometimes years, the plaintiff would be monitored.
Over the next two years, Dr. Lueg continued to monitor plaintiff and conduct blood tests to measure the functioning of plaintiff's thyroid. Until 1992, plaintiff's thyroid was functioning within normal parameters. However, a test conducted in September 1992 revealed that plaintiff's thyroid had begun to fail; thus, she was placed on thyroid hormone therapy. Although plaintiff's thyroid gland improved, by 1994, the gland showed evidence of further failure.
Plaintiff filed suit on April 8, 1991, against DIS, its owners, and the physicians involved in treating her, claiming negligence on their part for the misadministration of the isotope. She also requested a review by the Medical Review Panel and voluntarily dismissed her initial suit in light of an exception of prematurity filed by some of the defendants. On January 19, 1993, the Medical Review Panel rendered a unanimous opinion concluding that DIS and its physicians and owners failed to meet the applicable standard of care. Plaintiff subsequently filed a second suit on February 18, 1993.
In March of 1995, the plaintiffs entered into a settlement with DIS, its physicians and *1181 owners, and their insurer whereby the defendants agreed to pay plaintiff the statutory maximum of $100,000.00 in exchange for their release. However, plaintiff reserved her rights against the Louisiana Patient's Compensation Fund (LPCF) pursuant to the Medical Malpractice Act and brought suit against the LPCF on May 1, 1995. Plaintiff sought to recover damages for the negligence of DIS. The matter was tried before a jury on February 3, 4, and 5, 1997. At the close of plaintiff's case, LPCF moved for a partial directed verdict, seeking judgment in its favor as to the issues of hypothyroidism, increased risk of osteoporosis, and future medical expenses, arguing that plaintiff had failed to offer any medical evidence on those issues, but this motion was denied. The jury returned a verdict in favor of plaintiff and awarded her damages of $751,000.00. The award of damages was reduced by the judge to the statutory maximum of $500,000.00, minus the $100,000.00 credit to LPCF previously agreed upon for any judgment in excess of the $100,000.00. LPCF appeals this judgment of $400,000.00.
LAW AND ANALYSIS
Standard of Review
The standard of review for damage awards requires a showing that the trier of fact abused the great discretion accorded in awarding damages. Moore v. Healthcare Elmwood, Inc., 582 So.2d 871 (La.App. 5th Cir.1991). In effect, the award must be so high or low in proportion to the injury that it "shocks the conscience." Id. The discretion vested in the trier of fact is great, "even vast," so that an appellate court should rarely disturb an award of general damages. Youn v. Maritime Overseas Corp., 623 So.2d 1257 (La.1993), cert. denied, 510 U.S. 1114, 114 S.Ct. 1059, 127 L.Ed.2d 379 (1994).
First, LPCF claims that the jury bases its assessment of damages on expert testimony that was premised on an unsubstantiated assumption of fact and/or improper hypothetical questions and answers. Specifically, LPCF contends that Dr. Soll's and Dr. Mark Mandelkern's testimonies that appellee was subject to an increased risk of cancer were premised on the conclusion that appellee's thyroid was only damaged and not destroyed. However, the testimony of Dr. Lueg, who monitored appellee, finds appellee's thyroid to be completely destroyed. This distinction between a damaged and a fully destroyed thyroid makes a difference, because the potential of cancer decreases when enough thyroid cells are destroyed. Although our jurisprudence has recognized that an expert's opinion has no value if the facts on which it is predicated are not substantiated by the record, Nealy v. LeBlanc, 94-1057 (La.App. 1st Cir. 4/7/95), 654 So.2d 468, here, there is evidence that the misadministration of the isotope increased her risk of cancer. First, the record shows that the appellee was given a misadministered amount of isotopes but the level of the isotope is not in dispute. Second, although the record shows appellee suffered thyroid damage, the expert testimony differs as to the extent of damage. However, the experts who testified agreed that a damaged thyroid gland causes a significant increase in the risk of cancer. Furthermore, Dr. Soll informed the plaintiff, one day after the misadministration, that the increased level of the isotope would increase her risk of cancer. Although there may be contradictory expert testimony regarding the actual damage to the thyroid, our jurisprudence finds that where the testimony of expert witnesses differ, it is the responsibility of the trier of fact to determine which evidence is the most credible. Tullis v. Rapides Parish Police Jury, 95-905 (La. App. 3d Cir. 1/17/96), 670 So.2d 245. A factual finding, based upon a credibility determination, may not be disturbed on appeal absent manifest error. Id. A trial court's decision to accept the opinion of one expert and to reject that of another can virtually never be manifestly erroneous, unless the court was clearly wrong in accepting the expert's opinion upon which it has relied. Id. After a careful review of the entire record, we do not find the jury's decision to accept the testimonies of the experts to be clearly wrong.
Free access — add to your briefcase to read the full text and ask questions with AI
Related
Cite This Page — Counsel Stack
710 So. 2d 1178, 1998 WL 188758, Counsel Stack Legal Research, https://law.counselstack.com/opinion/stevenson-v-la-patients-comp-fund-lactapp-1998.